Plexus Corp. $PLXS Shares Sold by Versor Investments LP

Versor Investments LP lessened its holdings in shares of Plexus Corp. (NASDAQ:PLXS) by 28.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,913 shares of the technology company’s stock after selling 3,076 shares during the period. Versor Investments LP’s holdings in Plexus were worth $1,145,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in PLXS. Salomon & Ludwin LLC purchased a new position in shares of Plexus during the 3rd quarter valued at about $30,000. Huntington National Bank grew its holdings in Plexus by 41.5% during the second quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after acquiring an additional 95 shares during the period. CWM LLC grew its holdings in Plexus by 65.7% during the second quarter. CWM LLC now owns 537 shares of the technology company’s stock worth $73,000 after acquiring an additional 213 shares during the period. EverSource Wealth Advisors LLC raised its position in Plexus by 583.3% during the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after acquiring an additional 490 shares in the last quarter. Finally, Smartleaf Asset Management LLC lifted its holdings in Plexus by 33.0% in the third quarter. Smartleaf Asset Management LLC now owns 806 shares of the technology company’s stock valued at $115,000 after acquiring an additional 200 shares during the period. 94.45% of the stock is owned by hedge funds and other institutional investors.

Plexus Stock Up 1.0%

PLXS stock opened at $208.36 on Tuesday. Plexus Corp. has a 52 week low of $103.43 and a 52 week high of $211.84. The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 0.06. The firm has a 50-day simple moving average of $167.30 and a 200-day simple moving average of $149.00. The stock has a market capitalization of $5.58 billion, a P/E ratio of 32.40 and a beta of 0.81.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.01. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The company had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.07 billion. During the same period in the previous year, the firm posted $1.73 EPS. Plexus’s revenue was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Equities analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Patrick John Jermain sold 3,587 shares of the stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $204.09, for a total value of $732,070.83. Following the completion of the transaction, the chief financial officer directly owned 16,882 shares of the company’s stock, valued at approximately $3,445,447.38. This represents a 17.52% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of Plexus stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $203.06, for a total transaction of $873,767.18. Following the sale, the chief accounting officer directly owned 20,099 shares in the company, valued at approximately $4,081,302.94. This trade represents a 17.63% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 30,951 shares of company stock valued at $6,077,670 in the last three months. Company insiders own 1.78% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on PLXS shares. Weiss Ratings raised shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday. Needham & Company LLC increased their price target on shares of Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Sidoti cut shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price objective for the company. in a report on Friday, October 24th. Benchmark upped their price objective on shares of Plexus from $165.00 to $195.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, Stifel Nicolaus raised their target price on Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a research report on Friday, January 30th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $189.20.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.